Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Feature
  • Published:

Biotech's wellspring—a survey of the health of the private sector in 2016

Nature Biotechnology volume 35, pages 413–420 (2017)Cite this article

Subjects

Investment is skewing early as venture capitalists grapple with a volatile political environment, a hot stock market and a flagging IPO outlook.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Global amount and number of financings raised through venture capital funds, 2006–2016.
Figure 2: Venture capital investment by stage, number of deals by stage and total invested.
Figure 3: 2016 versus 2017 January and February US biotech venture capital raised and number of deals.
Figure 4: Global venture capital activity.
Figure 5: Global average amount invested per biotech venture capital round.
Figure 6: Exits, IPO funds raised and M&A value.

Author information

Authors and Affiliations

  1. Stacy Lawrence is a freelance writer based in Alameda, California.,

    Stacy Lawrence

Authors
  1. Stacy Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lawrence, S. Biotech's wellspring—a survey of the health of the private sector in 2016. Nat Biotechnol 35, 413–420 (2017). https://doi.org/10.1038/nbt.3867

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.3867

This article is cited by

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research